Lord, Abbett & Co’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
Sell
-678,443
Closed -$26.4M 1011
2014
Q2
$26.4M Buy
+678,443
New +$26.4M 0.06% 451
2013
Q4
Sell
-1,113,819
Closed -$26.2M 1073
2013
Q3
$26.2M Buy
+1,113,819
New +$26.2M 0.06% 448